204-2025 COVID-19 Vaccines
IMPORTANT INFORMATION:
The approved and authorized 2024–2025 COVID-19 vaccines have been updated to a monovalent vaccine based on the Omicron JN.1-lineage of SARS-CoV-2, KP.2. The vaccine is a close match to variants currently circulating and provides good protection against severe disease, hospitalization, and death.
The Department of Health offers walk-in COVID-19 vaccine (Pfizer BioNTech/Comirnarty or Moderna/Spikevax) clinics at the Parole, Glen Burnie and Magothy Health Centers for eligible individuals 6 months through 18 years old only. Wait times may vary. Limited supplies are available. Novavax vaccine is no longer available in the United States.
COVID-19 vaccines may also be available at pharmacies, from you or your child's health care provider, and federally qualified health centers.
COVID-19 Vaccine Recommendations
The Centers for Disease Control and Prevention (CDC) recommends that everyone ages 6 months and older get a 2024-2025 COVID-19 vaccine. There is no preferential recommendation for the use of any one COVID-19 vaccine over another. Children under 6 months of age are currently not authorized for any COVID-19 doses.
An 8-week interval between the first and second COVID-19 vaccine (Moderna, Novavax and Pfizer-BioNTech) doses may be optimal for some people as it may reduce the small risk of myocarditis and pericarditis.
6 months - 4 years
| If you… | You need… | When you need it: |
| are unvaccinated | 2 doses of the 2024-2025 Moderna vaccine OR 3 doses of the 2024-2025 Pfizer BioNTech vaccine | 4 to 8 weeks apart |
| 1 or more doses of Moderna vaccine | 1 dose of the 2024-2025 Moderna vaccine | 4 to 8 weeks after previous dose |
| 1 dose of Pfizer-BioNTech vaccine | 2 doses of the 2024-2025 Pfizer BioNTech vaccine | 1 dose 3 weeks after the initial dose, followed by the second dose 8 weeks later. |
| 2 or more doses of Pfizer-BioNTech vaccine | 1 dose of the 2024-2025 Pfizer BioNTech vaccine | 8 weeks after previous dose |
5 years and older
- 1 dose of the 2024–2025 Moderna/Spikevax OR
- 1 dose of the 2024–2025 Pfizer-BioNTech (Comirnaty)COVID-19 vaccine
65+ Spikevax (MODERNA) OR Comirnaty (PFIZER):
If you are ages 65 years and older, an additional COVID-19 vaccine dose—beyond what is listed above—is NOT currently recommended unless you are moderately or severely immunocompromised.
Individuals who are moderately or severely immunocompromised
There are different recommendations if you are moderately or severely immunocompromised; see Vaccines for Moderately to Severely Immunocompromised People.
COVID-19 Vaccine FAQ
Where can I get this updated COVID-19 vaccine?
If you have private insurance, Medicaid or Medicare, you can get COVID-19 vaccines at pharmacies or from your health care provider.
If you do not have health insurance or are underinsured you may be able to get free COVID-19 vaccines at Pharmacies, Federally Qualified Health Centers or your local health department.
The Department of Health expects to receive a limited supply of the updated COVID-19 vaccine that will be reserved for the following eligible population:
- Ages 6 months to 18 years who qualify for the Vaccines for Children Program
Visit www.vaccines.gov, to find a COVID-19 vaccine location near you.
If I had COVID recently, when should I get the updated vaccine?
If you’ve had COVID recently, the CDC recommends waiting three months since your symptoms began or, for asymptomatic cases, since you tested positive before getting the vaccine.